Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT01549964. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION -
ClinicalTrials.gov study NCT00637273. IPD Sharing: Not stated. Countries: 3. Publications: 8.
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
ClinicalTrials.gov study NCT04017832. IPD Sharing: YES. Countries: 9. Publications: 1.
Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
ClinicalTrials.gov study NCT01859793. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT02849080. IPD Sharing: YES. Countries: 10. Publications: 7.
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
ClinicalTrials.gov study NCT02623998. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
ClinicalTrials.gov study NCT02312063. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
ClinicalTrials.gov study NCT01519674. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
ClinicalTrials.gov study NCT07073768. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01177813. IPD Sharing: Not stated. Countries: 9. Publications: 4.
Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
ClinicalTrials.gov study NCT00666848. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
ClinicalTrials.gov study NCT03061214. IPD Sharing: YES. Countries: 7. Publications: 2.
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02607865. IPD Sharing: YES. Countries: 15. Publications: 9.
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT01829464. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01930188. IPD Sharing: Not stated. Countries: 18. Publications: 16.
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01652729. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
ClinicalTrials.gov study NCT00789191. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
ClinicalTrials.gov study NCT00734474. IPD Sharing: Not stated. Countries: 13. Publications: 7.
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
ClinicalTrials.gov study NCT01378117. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
ClinicalTrials.gov study NCT00870194. IPD Sharing: Not stated. Countries: 7. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.